The use of ethylendiamine (EDA) core polyamidoamine (PAMAM) dendrimer for suppression of lincRNA-RoR in breast cancer cell line MDA-MB-231
Publish place: 12th International Congress on Breast Cancer
Publish Year: 1394
نوع سند: مقاله کنفرانسی
زبان: English
View: 358
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
ICBCMED12_197
تاریخ نمایه سازی: 2 تیر 1397
Abstract:
Introduction & Aim: Recently, the roles of long non-coding RNAs (lncRNAs) have been identified in the development and progression of cancers. LincRNA-RoR, as a player in the cell programming, was first identified in induced pluripotent stem cells. lincRNA-RoR is also highly expressed in cancer cells, including breast tumor cells. Gene silencing using siRNAs as one of the most important classes of new generation of therapeutic agents, is particularly used for the reduction of target gene expression. A wellestablisheddelivery system is a key element in the safe and efficient successful gene silencing by siRNAs. In this study, PAMAM dendrimer was used as an effective carriers for siRNA molecules for silencing lincRNA-RoR. Methods: In this study, formation of the complex of ethylendiamine (EDA) core polyamidoamine (PAMAM) dendrimer fifth generation (G5) and siRNA were confirmed by agarose gel electrophoresis. The complex [G5 PAMAM dendrimer/lincRNA-RoR siRNA] transfected to MDA-MB 231 cells whose lincRNA-RoR gene is highly expressed. Its effect on lincRNA-RoR was investigated by total RNA isolation, cDNA synthesis and Real-Time PCR quantification in different times after silencing. Results: Agarose gel electrophoresis showed formation of the complex [G5 PAMAM dendrimer/siRNA lincRNA-RoR] in concentrations greater than 10:1 and in this concentration leads to efficient lincRNARoR gene silencing. Conclusion: According to our results, G5 PAMAM dendrimers can be a useful delivery system for siRNAssilencing against lincRNA-RoR.
Authors
Sara Kor
Stem Cell Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Mohammad Shafiee
Department of Medical Genetics, Golestan University of Medical Sciences, Gorgan, Iran
Vahid Erfani-Moghadam
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran